Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Dejaegher, Joost [VerfasserIn]   i
 Solie, Lien [VerfasserIn]   i
 Hunin, Zoé [VerfasserIn]   i
 Sciot, Raf [VerfasserIn]   i
 Capper, David [VerfasserIn]   i
 Siewert, Christin [VerfasserIn]   i
 Van Cauter, Sofie [VerfasserIn]   i
 Wilms, Guido [VerfasserIn]   i
 van Loon, Johan [VerfasserIn]   i
 Ectors, Nadine [VerfasserIn]   i
 Fieuws, Steffen [VerfasserIn]   i
 Pfister, Stefan [VerfasserIn]   i
 Van Gool, Stefaan W [VerfasserIn]   i
 De Vleeschouwer, Steven [VerfasserIn]   i
Titel:DNA methylation based glioblastoma subclassification is related to tumoral T-cell infiltration and patient survival
Verf.angabe:Joost Dejaegher, Lien Solie, Zoé Hunin, Raf Sciot, David Capper, Christin Siewert, Sofie Van Cauter, Guido Wilms, Johan van Loon, Nadine Ectors, Steffen Fieuws, Stefan M. Pfister, Stefaan W. Van Gool, and Steven De Vleeschouwer
Jahr:2021
Jahr des Originals:2020
Umfang:11 S.
Teil:volume:23
 year:2021
 number:2
 month:02
 pages:240-250
 extent:11
Fussnoten:Gesehen am 10.06.2021 ; First published: 01 November 2020
Titel Quelle:Enthalten in: Neuro-Oncology
Ort Quelle:Oxford : Oxford Univ. Press, 1999
Jahr Quelle:2021
Band/Heft Quelle:23(2021), 2 vom: Feb., Seite 240-250
ISSN Quelle:1523-5866
Abstract:Histologically classified glioblastomas (GBM) can have different clinical behavior and response to therapy, for which molecular subclassifications have been proposed. We evaluated the relationship of epigenetic GBM subgroups with immune cell infiltrations, systemic immune changes during radiochemotherapy, and clinical outcome.450K genome-wide DNA methylation was assessed on tumor tissue from 93 patients with newly diagnosed GBM, treated with standard radiochemotherapy and experimental immunotherapy. Tumor infiltration of T cells, myeloid cells, and Programmed cell death protein 1 (PD-1) expression were evaluated. Circulating immune cell populations and selected cytokines were assessed on blood samples taken before and after radiochemotherapy.Forty-two tumors had a mesenchymal, 27 a receptor tyrosine kinase (RTK) II, 17 RTK I, and 7 an isocitrate dehydrogenase (IDH) DNA methylation pattern. Mesenchymal tumors had the highest amount of tumor-infiltrating CD3+ and CD8+ T cells and IDH tumors the lowest. There were no significant differences for CD68+ cells, FoxP3+ cells, and PD-1 expression between groups. Systemically, there was a relative increase of CD8+ T cells and CD8+ PD-1 expression and a relative decrease of CD4+ T cells after radiochemotherapy in all subgroups except IDH tumors. Overall survival was the longest in the IDH group (median 36 mo), intermediate in RTK II tumors (27 mo), and significantly lower in mesenchymal and RTK I groups (15.5 and 16 mo, respectively).Methylation based stratification of GBM is related to T-cell infiltration and survival, with IDH and mesenchymal tumors representing both ends of a spectrum. DNA methylation profiles could be useful in stratifying patients for immunotherapy trials.
DOI:doi:10.1093/neuonc/noaa247
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1093/neuonc/noaa247
 DOI: https://doi.org/10.1093/neuonc/noaa247
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1760248401
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68747103   QR-Code
zum Seitenanfang